Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats
Journal of Proteome Research · 06.11.2026 · 25 (11) · 5862-5872
DOI: 10.1021/acs.jproteome.6c00357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 14.10.2026. Verfasst von Katelyn B Brusach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, The Ohio State University College of Veterinary Medicine, Columbus, Ohio43210, United States. Hauptthemen laut MEDLINE: Proteomics, Renal Insufficiency, Chronic, Cat Diseases, Proteome. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, College of Veterinary Medicine, Ohio State University, NIDDK NIH HHS.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is one of the most prevalent diseases in feline medicine. Mass spectrometry-based urinary proteomics offers powerful insight into biomarker candidates and disease subtyping in CKD by measuring protein profiles rather than individual proteins. This study aims to measure the urinary proteome to identify protein profiles in cats with and without CKD to gain pathophysiological insights into the disease and more precisely diagnose CKD. Here, we identify 2,219 urinary proteins in the feline urinary proteome. Using univariate biomarker analysis, we show that MMP-7 may be a promising biomarker of CKD in cats. We then demonstrate the power of using protein profiles rather than individual proteins by grouping proteins based on how they trend across disease states. The changes to the global urinary proteomes of individual cats showed three distinct groups of CKD cats with unique protein profiles, suggesting that different pathophysiological mechanisms mediate disease subtypes. We demonstrate that large-scale urinary proteomics may provide a powerful framework for discovering candidate biomarkers that advance the subtyping and mechanistic understanding of feline CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, The Ohio State University College of Veterinary Medicine, Columbus, Ohio43210, United States.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota55905, United States.
- Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio43210, United States.
- Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, Ohio43210, United States.
ORCID-Profile: Katelyn B Brusach
Förderung
- NIGMS NIH HHS
- College of Veterinary Medicine, Ohio State University
- NIDDK NIH HHS
- Pelotonia
- Zoetis
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Brusach, K. B., Shannon, A. E., Searle, B. C., & Quimby, J. M. (2026). Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats. Journal of Proteome Research, 25(11), 5862-5872. https://doi.org/10.1021/acs.jproteome.6c00357
Vancouver
Brusach KB, Shannon AE, Searle BC, Quimby JM. Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats. Journal of Proteome Research. 2026;25(11):5862-5872. doi:10.1021/acs.jproteome.6c00357
BibTeX
@article{Brusach2026,
author = {Brusach, Katelyn B and Shannon, Ariana E and Searle, Brian C and Quimby, Jessica M},
title = {Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {5862--5872},
doi = {10.1021/acs.jproteome.6c00357}
}
EUVIMED